Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies
Corresponding Author
Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
Research Unit in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand
Correspondence
Noppacharn Uaprasert, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital Rama IV Rd, Pathumwan, Bangkok 10330, Thailand.
Email: drnoppacharn@yahoo.com
Search for more papers by this author
Comments (0)